tadalafil has been researched along with Muscular Dystrophy, Duchenne in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cox, D; Dieye, I; Goemans, N; Hossain, I; Jenkins, M; Landry, J; Sajeev, G; Signorovitch, J; Van den Hauwe, M; Ward, SJ; Wong, B; Yao, Z | 1 |
| Byrne, B; Cox, D; Dubrovsky, AL; Eagle, M; Elashoff, R; Finkel, R; Furlong, P; Goemans, N; Landry, J; McDonald, CM; Miceli, MC; Sweeney, HL; Topaloglu, H; Vandenborne, K; Victor, RG | 1 |
| Elashoff, RM; Miceli, MC; Nelson, MD; Nelson, SF; Rader, F; Sweeney, HL; Tang, X; Tavyev, J; Victor, RG | 1 |
| Corbi, N; De Arcangelis, V; Di Certo, MG; Gabanella, F; Luvisetto, S; Magrelli, A; Mattei, E; Monaco, L; Naro, F; Onori, A; Passananti, C; Pisani, C; Rome, S; Severini, C; Strimpakos, G | 1 |
| Forbes, SC; Hammers, DW; Shima, A; Sleeper, MM; Sweeney, HL; Walter, GA | 1 |
| Anene, F; Barresi, R; Byrne, BJ; Elashoff, RM; Gurudevan, SV; Martin, EA; Scott, BL; Thomas, GD; Tsimerinov, EI; Victor, RG; Walker, AE | 1 |
4 trial(s) available for tadalafil and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
Prognostic factors for changes in the timed 4-stair climb in patients with Duchenne muscular dystrophy, and implications for measuring drug efficacy: A multi-institutional collaboration.
Topics: Adolescent; Child; Computer Simulation; Disease Progression; Exercise Test; Follow-Up Studies; Humans; Male; Muscular Dystrophy, Duchenne; Neuromuscular Agents; Prognosis; Sample Size; Tadalafil; Walking | 2020 |
A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy.
Topics: Adolescent; Area Under Curve; Child; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Glucocorticoids; Heart Rate; Humans; International Cooperation; Male; Muscular Dystrophy, Duchenne; Quality of Life; Respiratory Function Tests; Tadalafil; Treatment Outcome; Vasodilator Agents; Ventricular Function, Left; Walking | 2017 |
PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy.
Topics: Adolescent; Carbolines; Child; Exercise; Forearm; Humans; Ischemia; Male; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Spectroscopy, Near-Infrared; Sulfones; Sympathetic Nervous System; Tadalafil; Ultrasonography; Vasoconstriction | 2014 |
Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.
Topics: Adolescent; Adult; Animals; Biopsy; Carbolines; Child; Child, Preschool; Humans; Immunohistochemistry; Ischemia; Male; Mice; Middle Aged; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Phosphodiesterase 5 Inhibitors; Sympatholytics; Tadalafil; Young Adult | 2012 |
2 other study(ies) available for tadalafil and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
Pathways Implicated in Tadalafil Amelioration of Duchenne Muscular Dystrophy.
Topics: Animals; Female; Lipid Metabolism; Male; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphodiesterase 5 Inhibitors; Tadalafil; Transcription Factors; Up-Regulation | 2016 |
Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin-Deficient Hearts.
Topics: Animals; Cardiomyopathies; Cardiotonic Agents; Disease Models, Animal; Dogs; Dystrophin; Echocardiography; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred mdx; Muscular Dystrophy, Duchenne; Tadalafil; TRPC6 Cation Channel | 2016 |